As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
|Articles|August 30, 2022
- August 2022
- Volume 88
- Issue 8
Pet Peeves: August 2022
Brought to you by The Sassy Pharmacist
Advertisement
Search Party
Patients who ask for a refill and then put the pharmacy on hold to look for the bottle.
Butt Out
Customers who smoke in the drive-through.
No-Shows
Patients who demand a partial fill and do not come to get the completion.
What's Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to cmollison@pharmacytimes.com. We’ll share them here and online.
Articles in this issue
about 4 years ago
Case Studies: August 2022about 4 years ago
OTC Case Studies: Vitamins and Supplementsabout 4 years ago
Dartisla ODT From Edenbridge Pharmaceuticalsabout 4 years ago
Cultural Competence Sets Pharmacy Professionals Apartabout 4 years ago
Foot Care Is Essential for Patients With Diabetesabout 4 years ago
Generic Product News: August 2022about 4 years ago
Knowing Which OTC Drugs Patients Are Taking Is Vitalabout 4 years ago
Illinois Business Partners With Hospital to Reduce Readmissionsabout 4 years ago
Rx Product News: August 2022Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
The first AHA endocarditis update in 11 years expands outpatient options, with a bigger role for pharmacists.
A suspected plague death in Russia has renewed attention on the rare infection. Here's how to spot pneumonic plague, and which antibiotics the CDC recommends.
A meta-analysis of 27 trials found 15% lower cardiovascular (CV) event risk per 10-mm Hg SBP reduction, with eGFR declines but no rise in kidney failure.
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
Could CAR T Therapy Become Adjustable After Infusion?
3
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
4
Using CKDintercept to Build Interdisciplinary Kidney Care
5